RNA, U7 small nuclear 197 pseudogeneGenealiases: []
Q-omics provides the consensus-scored RNU7-197P profile across patient tissues and cancer cell-line models. RNU7-197P expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, RNU7-197P is differentially expressed in 2, with the highest sampling consensus in THCA. Additionally, RNU7-197P RNA expression shows 8,939 significant gene co-expression associations, with the highest sampling consensus in LUSC. Together, these results highlight KICH, THCA, and LUSC as cancer lineages where RNU7-197P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU7-197P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU7-197P survival associations across molecular data types. RNU7-197P RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU7-197P RNA expression–survival associations across cancer types. High RNU7-197P expression shows unfavorable associations in KICH, ACC, PAAD, LIHC and KIRC, but favorable associations in STAD. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for RNU7-197P RNA expression.
This table summarizes RNU7-197P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for RNU7-197P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU7-197P shows lower tumor expression in THCA and BRCA. The THCA box plot shows higher RNU7-197P RNA expression in normal versus tumor tissue (log2 FC = −0.229, t-test p = .018).
This table shows molecular features associated with RNU7-197P in patient tissues and cancer cell lines. In patient samples, RNU7-197P shows the broadest associations at the RNA and protein expression levels, with LUSC recurring as the lineage with the largest associated feature set.
